SCHEMBL1034510

SCHEMBL1034510

O=S(=O)(c1cccc(-c2ccnc(NC3CCCCC3)n2)c1)N1CCCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 11/20 0.57
MAPK8 P45983 2/20 0.57
CHUK O15111 1/20 0.53
MAPK9 P45984 1/20 0.53
MAPK10 P53779 1/20 0.53
MAPK11 Q15759 1/20 0.53
MAPK14 Q16539 1/20 0.53
USP2 O75604 2/20 0.53
ALDH1A1 P00352 2/20 0.53
HPGD P15428 2/20 0.53
GAA P10253 2/20 0.53
KDM4E B2RXH2 1/20 0.53
ESR1 P03372 1/20 0.53
GLA P06280 1/20 0.53
HSD17B10 Q99714 1/20 0.53
NPSR1 Q6W5P4 1/20 0.51
HTT P42858 1/20 0.49
DGAT1 O75907 1/20 0.49
MEN1 O00255 1/20 0.48
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1033479 0.85 PTGS2 (0.55) IKBKBMAPK8MAPK9MAPK10
SCHEMBL1031156 0.83 ALDH1A1 (0.53) IKBKBMAPK8MAPK9MAPK10ALDH1A1
SCHEMBL1033696 0.78 MTOR (0.61) MAPK10ALDH1A1HPGDDGAT1MEN1
SCHEMBL3619159 0.76 ADORA1 (0.59) IKBKBMAPK8MAPK9MAPK10DGAT1
SCHEMBL1028968 0.76 MAP4K4 (0.55) IKBKBMAPK8MAPK9MAPK10GAA
SCHEMBL1033626 0.76 CDK1 (0.53) IKBKBMAPK8MAPK9MAPK10MAPK14
SCHEMBL1030530 0.76 ADORA1 (0.59) IKBKBMAPK8MAPK9MAPK10DGAT1
SCHEMBL1033986 0.76 PTK2 (0.49) IKBKBDGAT1
SCHEMBL1030447 0.75 MAPK14 (0.52) MAPK8MAPK10MAPK14DGAT1
SCHEMBL1033097 0.73 MKNK1 (0.57) MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed